GV1001 Subcutaneous(SC) for the Treatment of Moderate Alzheimer's Disease (AD)

Condition:   Moderate Alzheimer's Disease Interventions:   Drug: GV1001;   Drug: Normal saline Sponsor:   GemVax & Kael Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Alzheimer's | Research